CLN3 and glycogen storage disease VI: Taken together, our findings demonstrate the utility of ASO-based reading frame correction as an approach to treat CLN3 Batten disease retinal dysfunction and demonstrate the activity of an ASO specific for human CLN3∆78 in vivo.